Biomarkers for respiratory diseases: Present applications and future discoveries
Clinical and Translational Discovery · 2021
DOI: 10.1002/ctd2.11 ↗At a glance
Journal article in Clinical and Translational Discovery, 2021. Written by Xiaojing Liu and 5 co-authors. Cited 12 times so far (Crossref); 117 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (original language)
Biomarkers such as clinical characteristics and laboratory indices have been widely used in many respiratory diseases, such as chronic airway diseases, lung infection, lung cancer and acute respiratory distress syndrome. As such, various non‐invasive and invasive samples, such as blood, urine, induced sputum, bronchoalveolar lavage fluid and lung biopsy are currently being collected. Omics‐based discovery strategies facilitate the identification of next‐generation candidate biomarkers. The identification and integration of multiple omics biomarkers (genomics, epigenomics, proteomics, metabolomics and radiomics) can answer many unsolved questions about respiratory diseases. The ultimate realization of the translation of novel biomarkers into clinical practice is a major challenge because good biomarkers must be sensitive, technically feasible, non‐invasive, non‐expensive and most importantly, validated. The four stages of clinical trial design in the development of biomarkers are also discussed. The concept of systems biology not only focuses on novel molecular biomarkers but also integrates clinical, laboratory and omics information as a whole. Finally, developing multiple biomarker panels is a goal to improve the healthcare of respiratory diseases.
Funding
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Cite
APA
Liu, X., Cui, B., Wang, Q., Ma, Y., Li, L., & Chen, Z. (2021). Biomarkers for respiratory diseases: Present applications and future discoveries. Clinical and Translational Discovery. https://doi.org/10.1002/ctd2.11
Vancouver
Liu X, Cui B, Wang Q, Ma Y, Li L, Chen Z. Biomarkers for respiratory diseases: Present applications and future discoveries. Clinical and Translational Discovery. 2021. doi:10.1002/ctd2.11
BibTeX
@article{Liu2021,
author = {Liu, Xiaojing and Cui, Bo and Wang, Qian and Ma, Yuan and Li, Li and Chen, Zhihong},
title = {Biomarkers for respiratory diseases: Present applications and future discoveries},
journal = {Clinical and Translational Discovery},
year = {2021},
doi = {10.1002/ctd2.11}
}
EUVIMED